ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 168 filers reported holding ZAI LAB LTD in Q3 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,734,039 | -21.3% | 134,657 | -5.6% | 0.02% | -20.7% |
| Q1 2023 | $4,746,601 | -67.5% | 142,712 | -70.0% | 0.03% | -63.8% |
| Q4 2022 | $14,582,868 | -36.4% | 475,012 | -29.2% | 0.08% | -31.0% |
| Q3 2022 | $22,933,000 | +3.8% | 670,565 | +5.2% | 0.12% | +23.4% |
| Q2 2022 | $22,097,000 | +41.9% | 637,181 | +80.0% | 0.09% | +49.2% |
| Q1 2022 | $15,568,000 | +26.3% | 353,968 | +80.5% | 0.06% | -12.5% |
| Q4 2021 | $12,328,000 | -26.2% | 196,144 | +23.8% | 0.07% | -20.9% |
| Q3 2021 | $16,703,000 | -0.2% | 158,488 | +67.6% | 0.09% | -15.0% |
| Q2 2021 | $16,740,000 | +28.6% | 94,580 | -3.1% | 0.11% | -7.0% |
| Q1 2021 | $13,020,000 | -27.2% | 97,578 | -26.2% | 0.12% | -25.8% |
| Q4 2020 | $17,895,000 | +101.5% | 132,224 | +23.8% | 0.16% | +44.9% |
| Q3 2020 | $8,880,000 | +69.4% | 106,769 | +67.3% | 0.11% | +21.6% |
| Q2 2020 | $5,243,000 | – | 63,837 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
| XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
| Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
| Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
| Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
| Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
| BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
| Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
| Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
| Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |